Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
68 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Orifarm Belgium from Gent, company number BE0736472401, closed financial year 2025 with a result of € 377,447 after tax. For that financial year Orifarm Belgium recorded a gross margin of € 1.1 million and equity of € 729,475. Compared with financial year 2024, the result moved from € 175,053 to € 377,447. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 6, 2026.
€ 729,475
▲ 107% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 377,447
▲ 116% vs 2024
Profit after tax over the fiscal year.
€ 2.7 million
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 719,475.
People and assets in 2025
2.8
▲ 0.7 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 369,499
▲ 14% vs 2024
€ 132,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1.7 million
▼ 1% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 288,670
▲ 42% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 541,610 | € 479,404 | € 779,664 | € 1,093,546 | ▲ 40% |
| Profit after taxes | € 46,921 | € 70,319 | € 175,053 | € 377,447 | ▲ 116% |
| Equity | € 106,656 | € 176,975 | € 352,028 | € 729,475 | ▲ 107% |
| Total debts | € 1,992,236 | € 1,830,977 | € 5,390,268 | € 4,270,361 | ▼ 21% |
| Cash | € 0 | € 209,374 | € 0 | € 2,654,905 | |
| Retained profit | € 96,656 | € 166,975 | € 342,028 | € 719,475 | ▲ 110% |
| Bank debt | € 497,131 | € 0 | € 2,110,571 | € 0 | ▼ 100% |
| Balance sheet total | € 2,098,893 | € 2,007,952 | € 5,742,296 | € 4,999,836 | ▼ 13% |
| Employees (FTE) | 2.2 | 1.5 | 2.1 | 2.8 | ▲ 0.7 |
Key figures of Orifarm Belgium, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Orifarm Belgium?
What happened at Orifarm Belgium in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 377,447 (▲ 116% vs 2024). Source: NBB ↗
- Nicki Lund Kristensen became a director. NBB
- Mads Fink Eriksen became a director. NBB
- Hans Carl Boegh-Soerensen became a director. NBB
- New establishment in Gent. KBO
- Thomas Brandhof became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 46,921 profit in 2022 to € 377,447 profit in 2025.
Paid € 246,689 in corporate taxes since 2022.
Best year ever: 2025, with € 377,447 profit.
On average € 390,600 of value added per employee in 2025.
A new publication or filing at Orifarm Belgium? We notify you, reason included.
Follow Orifarm BelgiumDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Orifarm Belgium are Thomas Brandhof, Nicki Lund Kristensen, Mads Fink Eriksen and Hans Carl Boegh-Soerensen. The same people are also behind Orifarm Healthcare. Thomas Brandhof is also behind Affordable Medicines Europe.
Directors
According to the 2025 annual accounts
since 2019
since 2025
since 2025
since 2025
Establishments
Establishment units
Physical locations of this company
Gaston Crommenlaan 8
9050 Gent
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 68 companies are registered at this address.
All companies at this address →ELDEMAR
€ 4.8 million gross margin · 2025
Petanque Mouscron
Iptor Belgium
€ 6.2 million revenue · 2025
1Enclose
€ 43,088 gross margin · 2025
FLUKE BELGIUM
€ 11.4 million revenue · 2025
+63 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0736.472.401
- VAT number
- BE 0736.472.401
- Registered office
- Gaston Crommenlaan 8, 9050 Gent
- Names & denominations
- Orifarm Belgium
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 16 October 2019
- Peppol
- Active · Active since 11 Jun 2026
- Activities · NACE
Groothandel in farmaceutische en medische artikelen